Prenatal Testing & Newborn Screening Market - Forecast(2022 - 2027)

Report Code: HCR 0081 Report Format: PDF + Excel

Prenatal Testing & Newborn Screening Market Overview

Prenatal Testing & Newborn Screening Market size is forecast to reach $15,729 million by 2027, growing at a CAGR of 11.2% during the forecast period 2022-2027. Prenatal Testing and Newborn Screening is one of the advanced techniques that is used in the healthcare industry to identify the defects at a very early stage. It is also used for checking the presence of genetic disorders that includes Tay-Sachs disease, cystic fibrosis, sickle cell anaemia and Down’s syndrome among others. Screening is further continued after a baby is born, called newborn genetic testing to check for genetically inherited diseases or congenital anomalies such as phenylketonuria (PKU), muscular spinal atrophy, critical congenital heart disease, hearing loss, and others. The growing awareness towards pediatric diseases and efforts laid by organizations such as Save Babies Through Screening Inc. and National Health Service for screening programmes are the major factors driving the growth of the market. The development of advanced technologies such as tandem mass spectrometry that allows screening of above 50 disorders and increasing demand for prenatal testing is set to further enhance the overall market developments of the Prenatal Testing & Newborn Screening Market for the period 2022-2207.

Report Coverage

The report: “Prenatal Testing & Newborn Screening Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Prenatal Testing & Newborn Screening Market. 
By Product: Instruments, Reagents, Assay Kits, and Others
By Diagnosing Technique: Non Invasive (Ultrasonography, Pre-implementation Genetic Diagnosis, Fetal Cells in Maternal Circulation, and Fetus Free Fetal DNA), and Invasive ( Amniocentesis, Chronic Villus Sampling, Fetal Blood Sampling, and Embryoscopy % Fetoscopy)
By Screening Option: First Trimester (Nuclear Translucency, and Serum Screening), and Second Trimester (Triple Screen, Quadruple Screen, Genetic Sonograms, Extended Sonograms, Sequential Screening, and Ultrasonography)
By Technology: Tandem Mass Spectrometry, Electrophoresis, Enzymes & Immuno Assays, DNA Based Assays, Pulse Oximetry Technology, and Hearing Screen Technology
By Geography: North America (U.S., Canada, Mexico), South America (Brazil, Argentina, Chile, Columbia, and Rest of South America), Europe (Germany, France, U.K. (United Kingdom), Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan, South Korea, India, Australia & New Zealand, and Rest of Asia Pacific), and Rest of the World (Middle East, and Africa)

Key Takeaways

  • North America dominated the Prenatal Testing & Newborn Screening Market in 2021 owing to the increasing need of new testing techniques and increasing usage of non-invasive diagnose method that is being widely adopted as the growing number of women are choosing to become pregnant at an advanced maternal age. The Prenatal Testing & Newborn Screening Market scope for different regions will be provided in the final report.
  • Increasing demand for detecting genetic abnormalities in the prenatal and newborn population are likely to aid the market growth of the Prenatal Testing & Newborn Screening Market report.
  • Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be Prenatal Testing & Newborn Screening Market report.
  • Several ethical concerns related to prenatal and new-born testing & lack of standardization of newborn testing policies and procedures is poised to create the hurdles for the Prenatal Testing & Newborn Screening Market.

Prenatal Testing & Newborn Screening Market Revenue Share, By Geography, 2021(%)

For more details on this report - Request for Sample

Prenatal Testing & Newborn Screening Market Analysis – By Diagnosing Technique

Amniocentesis held the largest share in the Prenatal Testing & Newborn Screening Market in 2021 and is estimated to grow at a CAGR 12.3% during the forecast period 2022-2027. Amniocentesis is generally done after an abnormal triple test result. It helps to determine the fetal anemia severity in babies with Rh disease, and assists the physician to decide on the need for lifesaving blood transfusions of fetus. It is also used to diagnose chromosomal conditions, blood disorders, neural tube defects, musculoskeletal disorders and other genetic conditions. Potential risks and side effects such as miscarriage and others associated with the amniocentesis diagnosis are anticipated to hinder the growth of the number of amniocentesis diagnosis procedure. However, strict precautions taken by the healthcare provider is poised to exhibit an overall positive growth by reducing the instances of potential risks and side effects associated with amniocentesis diagnosis. Ultrasonography technique is used for identifying the abnormalities in the size of the fetus and placenta and also the amount of amniotic fluid during 16 to 20 weeks gestation. Ultrasonography is estimated to register the higher CAGR over the period 2022-2027.

Prenatal Testing & Newborn Screening Market Analysis – By Technology

Enzymes & Immuno Assays held the largest share in the Prenatal Testing & Newborn Screening Market in 2021 and is estimated to grow at a CAGR 8.7% during the forecast period 2022-2027. This is owing to the fact that it is primarily used in immunology to detect the presence of an antibody or an antigen in a sample. It is also used for the quantitative determination of Immunoreactive Trypsin (IRT) in human newborn blood spot samples and also for neonatal screening of cystic fibrosis (CF). Increasing demand for detecting genetic abnormalities in the prenatal and new-born population is also contributing to the market expansion. Additionally, heavy investment in research activities, extensive research associated with proteomics and genomics have led to significant developments in technology. Woman infected with the rubella virus during pregnancy can transmit the disease to her baby and leads to serious birth defects such as cataracts and other eye problems, hearing impairment, and heart disease. Miscarriage and stillbirth are also possible consequences for pregnant women thus to eradicate these concerns growth of enzyme immunoassay screening tool is witnessed. Prenatal and new-born genetic testing is significant in determination of various options during pregnancy to improvise the health outlook for the baby. Enzymes and Immunoassays helps in prevention of infant mortalities and enhances patient outcomes. Pulse Oximetry Technology are estimated to register the higher CAGR over the period 2022-2027.

Prenatal Testing & Newborn Screening Market Analysis – By Geography

North America dominated the Prenatal Testing & Newborn Screening Market with a major share of 41.4% in 2021. This is owing to the fact that prenatal testing and newborn screening testing are very accurate and effective and for several disorders only single test is required and this reason has led to the growth of the market in U.S. As prenatal testing and newborn screening provides various diagnostic techniques such as Ultrasonography, Pre-implementation Genetic Diagnose, Amniocentesis, Cvs and other diagnostic methods that uses advanced technologies has led to the demand of prenatal testing in U.S. 
However, Asia Pacific is estimated to grow at a higher CAGR during the forecast period 2021-2026 owing to the presence of a well-developed healthcare infrastructure. The Japanese healthcare system is one of the most advanced in the Asia Pacific region. This ensures that both urban and rural regions of the country receive access to high quality prenatal testing and newborn screening. Besides, the public health insurance system of Japan that covers most of the country’s citizens pays around 70% of the medical costs. This has led to a high demand for prenatal testing and newborn screening as the services are can be availed at low costs. 

Prenatal Testing & Newborn Screening Market Drivers 

The technological progressions and introduction of advanced products fuels the market growth 

The technological progressions and introduction of advanced products fuels the market growth, thereby increasing the growth of the Prenatal Testing & Newborn Screening Market. With the emergence of advanced technologies such as next generation sequencing, high throughput screening, and cell free fetal DNA, there has been a steady growth in the overall demand of the newly developed prenatal diagnosis and newborn screening tests. The newborn screening has been a great example of how technology and research advance health, from the past six decades. In the early 2000s, disorders were screening for, on average, 4 conditions. Today, most states screen for over 30 conditions. This increase is due to advancements in technology and the advocacy efforts of families. With rising incidence of diseases, rapid innovations in technology in medical field, and government initiative in spending for research and development, the newborn screening market is expected to have tremendous growth. Thus, increasing the demand of market during the forecast period 2022-2027.

Prenatal Testing & Newborn Screening Market Challenges

Ethical concerns related to prenatal and new-born testing & lack of standardization of newborn testing policies and procedures 
Some of the factors that are set to impede the growth of the Prenatal Testing & Newborn Screening Market are the several ethical concerns related to prenatal and new-born testing & lack of standardization of newborn testing policies and procedures. Newborn screening programs is one of the most successful public health initiatives of modern times. The number of tests included in the nationally recommended uniform screening panel (RUSP) has grown steadily to 34, with some states screening for as many as 58 conditions. Despite this, newborn screening has some disadvantages. Many countries have different procedures for how babies blood gets collected and transported from hospitals to state labs, different testing methods and turnaround times, and different approaches for interpreting results, including setting cutoffs. These differences, were brought into sharp focus via a series of media reports. Medicare funds only a small number of genetic tests and this may act as a barrier to implementing some screening programs and as a disincentive to preventive screening in general practice. Children may have particular problems dealing with the psychosocial effects of knowing that they have a genetic. Thus, hindering the growth of the market during the forecast period 2022-2027.

Prenatal Testing & Newborn Screening Market Landscape

Product launches, mergers and acquisitions, joint ventures, and R&D activities are key strategies adopted by players in the Prenatal Testing & Newborn Screening Market. In 2021, the Prenatal Testing & Newborn Screening Market share is consolidated by the top ten players present in the market. The Prenatal Testing & Newborn Screening Market, top 10 companies are-
  1. Perkin Elmer
  2. Progenity
  3. Laboratory Corporation of America Holdings
  4. Natera
  5. Invitae
  6. Centogene
  7. Roche Diagnostics
  8. Quest Diagnostics
  9. Eluthia
  10. Agilent

Recent Developments

  • In March 2020, Agilent introduced Agilent GenetiSure Cyto microarrays that includes three novel microarrays to meet the requirements of institutions and laboratories engaged in prenatal and postnatal research. This launch helped the company to gain competitive advantage and strengthen its industrial position.
  • In June 2019, BGI Genomics and Eluthia launched non-invasive prenatal test in Germany, providing prenatal diagnosis for 96 genetic conditions. This geographical expansion assisted the company in driving the product sales in Germany.

Relevant Titles:

Genetic Testing Market - Forecast(2022 - 2027)
Report Code: HCR 0084

Report Code: HCR 83007

For more Lifesciences and Healthcare related reports, please click here
1. Prenatal Testing & Newborn Screening Market Overview
    1.1 Definitions and Scope
2. Prenatal Testing & Newborn Screening Market - Executive Summary
3. Prenatal Testing & Newborn Screening Market– Market Landscape 
    3.1 Company Benchmarking- Key Companies
    3.2 Key Company Financial Analysis
    3.3 Market Share Analysis
    3.4 Patent Analysis
    3.5 Pricing Analysis (Comparison of General Price Offerings in the Market)
4. Prenatal Testing & Newborn Screening Market– Startup Company Scenario (Premium)
    4.1 Investment
    4.2 Revenue
    4.3 Venture Capital and Funding Scenario 
5. Prenatal Testing & Newborn Screening Market– Industry Market Entry Scenario Premium (Premium)
    5.1 Regulatory Scenario
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Prenatal Testing & Newborn Screening Market- Market Forces
    6.1 Market Drivers
    6.2 Market Constraints
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes 
7. Prenatal Testing & Newborn Screening Market– By Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle Analysis 
8. Prenatal Testing & Newborn Screening Market - By Product (Market Size –$Million/$Billion)  
    8.1 Instruments 
    8.2 Reagents
    8.3 Assay Kits
    8.4 Others
9. Prenatal Testing & Newborn Screening Market - By Diagnosing Technique (Market Size –$Million/$Billion)  
    9.1 Non Invasive  
        9.1.1 Ultrasonography
        9.1.2 Pre-implementation Genetic Diagnosis
        9.1.3 Fetal Cells in Maternal Circulation
        9.1.4 Fetus-Free Fetal DNA
    9.2 Invasive
        9.2.1 Amniocentesis
        9.2.2 Chorionic Villus Sampling (CVS)
        9.2.3 Fetal Blood Sampling
        9.2.4 Embryoscopy & Fetoscopy
10. Prenatal Testing Market - By Screening Option (Market Size –$Million/$Billion) 
    10.1 First Trimester
        10.1.1 Nuclear Translucency (NT)
        10.1.2 Serum Screening
    10.2 Second Trimester
        10.2.1 Triple Screen
        10.2.2 Quadruple Screen
        10.2.3 Genetic Sonograms
        10.2.4 Extended Sonogram
    10.3 Sequential Screening
    10.4 Ultrasonography
11. Newborn Screening Market - By Technology (Market Size –$Million/$Billion)  
    11.1 Tandem Mass Spectrometry
    11.2 Electrophoresis
    11.3 Enzymes and Immuno Assays
    11.4 DNA Based Assays
    11.5 Pulse Oximetry Technology
    11.6 Hearing Screen Technology
12. Prenatal Testing & Newborn Screening Market- By Geography (Market Size -$Million/Billion)
    12.1 North America
        12.1.1 U.S
        12.1.2 Canada
        12.1.3 Mexico
    12.2 South America
        12.2.1 Brazil
        12.2.2 Argentina
        12.2.3 Chile
        12.2.4 Colombia
        12.2.5 Rest of South America
    12.3 Europe
        12.3.1 Germany
        12.3.2 France
        12.3.3 UK
        12.3.4 Italy
        12.3.5 Spain
        12.3.6 Russia
        12.3.7 Rest of Europe
    12.4 APAC
        12.4.1 China
        12.4.2 Japan
        12.4.3 South Korea
        12.4.4 India
        12.4.5 Australia & New Zealand
        12.4.6 Rest of APAC
    12.5 ROW
        12.5.1 Middle East
        12.5.2 Africa
13. Prenatal Testing & Newborn Screening Market- Market Entropy
    13.1 New product launches
    13.2 M&A's, collaborations, JVs and partnerships
14. Prenatal Testing & Newborn Screening Market– Industry Competition Landscape (Premium)
    14.1 Market Share Analysis
        14.1.1 Global Market Share – Key Companies
        14.1.2 Market Share by Region – Key Companies
        14.1.3 Market Share by Countries – Key Companies
    14.2 Competition Matrix
    14.3 Best Practices for Companies
15. Prenatal Testing & Newborn Screening Market– Key Company List by Country Premium (Premium)
16. Prenatal Testing & Newborn Screening Market- Company Analysis 
    16.1 PerkinElmer
    16.2 Progenity
    16.3 Laboratory Corporation of America Holdings)
    16.4 Natera
    16.5 Invitae
    16.6 Centogene
    16.7 Roche Diagnostics
    16.8 Quest Diagnostics
    16.9 Progenity
    16.10 Ravgen and more
"*Financials would be provided on a best-efforts basis for private companies" 
List of Tables:
Table 1: Prenatal Testing & Newborn Screening Market Overview 2021-2026
Table 2: Prenatal Testing & Newborn Screening Market Leader Analysis 2018-2019 (US$)
Table 3: Prenatal Testing & Newborn Screening Market Product Analysis 2018-2019 (US$)
Table 4: Prenatal Testing & Newborn Screening Market End User Analysis 2018-2019 (US$)
Table 5: Prenatal Testing & Newborn Screening Market Patent Analysis 2013-2018* (US$)
Table 6: Prenatal Testing & Newborn Screening Market Financial Analysis 2018-2019 (US$)
Table 7: Prenatal Testing & Newborn Screening Market Driver Analysis 2018-2019 (US$)
Table 8: Prenatal Testing & Newborn Screening Market Challenges Analysis 2018-2019 (US$)
Table 9: Prenatal Testing & Newborn Screening Market Constraint Analysis 2018-2019 (US$)
Table 10: Prenatal Testing & Newborn Screening Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Prenatal Testing & Newborn Screening Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Prenatal Testing & Newborn Screening Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Prenatal Testing & Newborn Screening Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Prenatal Testing & Newborn Screening Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Prenatal Testing & Newborn Screening Market Value Chain Analysis 2018-2019 (US$)
Table 16: Prenatal Testing & Newborn Screening Market Pricing Analysis 2021-2026 (US$)
Table 17: Prenatal Testing & Newborn Screening Market Opportunities Analysis 2021-2026 (US$)
Table 18: Prenatal Testing & Newborn Screening Market Product Life Cycle Analysis 2021-2026 (US$)
Table 19: Prenatal Testing & Newborn Screening Market Supplier Analysis 2018-2019 (US$)
Table 20: Prenatal Testing & Newborn Screening Market Distributor Analysis 2018-2019 (US$)
Table 21: Prenatal Testing & Newborn Screening Market Trend Analysis 2018-2019 (US$)
Table 22: Prenatal Testing & Newborn Screening Market Size 2018 (US$)
Table 23: Prenatal Testing & Newborn Screening Market Forecast Analysis 2021-2026 (US$)
Table 24: Prenatal Testing & Newborn Screening Market Sales Forecast Analysis 2021-2026 (Units)
Table 25: Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Types, 2021-2026 ($)
Table 26: Prenatal Testing & Newborn Screening Market By Types, Revenue & Volume, By Screening Tests, 2021-2026 ($)
Table 27: Prenatal Testing & Newborn Screening Market By Types, Revenue & Volume, By Diagnosis Tests, 2021-2026 ($)
Table 28: Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Diagnosing Technique, 2021-2026 ($)
Table 29: Prenatal Testing & Newborn Screening Market By Diagnosing Technique, Revenue & Volume, By Non Invasive, 2021-2026 ($)
Table 30: Prenatal Testing & Newborn Screening Market By Diagnosing Technique, Revenue & Volume, By Invasive, 2021-2026 ($)
Table 31: Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Technology, 2021-2026 ($)
Table 32: Prenatal Testing & Newborn Screening Market By Technology, Revenue & Volume, By Tandem Mass Spectrometry, 2021-2026 ($)
Table 33: Prenatal Testing & Newborn Screening Market By Technology, Revenue & Volume, By Electrophoresis, 2021-2026 ($)
Table 34: Prenatal Testing & Newborn Screening Market By Technology, Revenue & Volume, By Enzymes and Immuno Assays, 2021-2026 ($)
Table 35: Prenatal Testing & Newborn Screening Market By Technology, Revenue & Volume, By DNA Based Assays, 2021-2026 ($)
Table 36: Prenatal Testing & Newborn Screening Market By Technology, Revenue & Volume, By Pulse Oximetry Technology, 2021-2026 ($)
Table 37: Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Screening Options, 2021-2026 ($)
Table 38: Prenatal Testing & Newborn Screening Market By Screening Options, Revenue & Volume, By First Trimester, 2021-2026 ($)
Table 39: Prenatal Testing & Newborn Screening Market By Screening Options, Revenue & Volume, By Second Trimester, 2021-2026 ($)
Table 40: Prenatal Testing & Newborn Screening Market By Screening Options, Revenue & Volume, By Third Trimester, 2021-2026 ($)
Table 41: Prenatal Testing & Newborn Screening Market By Screening Options, Revenue & Volume, By Sequential Screening, 2021-2026 ($)
Table 42: Prenatal Testing & Newborn Screening Market By Screening Options, Revenue & Volume, By Ultrasonography, 2021-2026 ($)
Table 43: Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Instruments, 2021-2026 ($)
Table 44: Prenatal Testing & Newborn Screening Market By Instruments, Revenue & Volume, By Hearing screen instruments, 2021-2026 ($)
Table 45: Prenatal Testing & Newborn Screening Market By Instruments, Revenue & Volume, By Reagent Assay Kits, 2021-2026 ($)
Table 46: Prenatal Testing & Newborn Screening Market By Instruments, Revenue & Volume, By Ultrasonography, 2021-2026 ($)
Table 47: Prenatal Testing & Newborn Screening Market By Instruments, Revenue & Volume, By Tandem Quadrupole Detector, 2021-2026 ($)
Table 48: Prenatal Testing & Newborn Screening Market By Instruments, Revenue & Volume, By Incubator Shaker, 2021-2026 ($)
Table 49: North America Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Types, 2021-2026 ($)
Table 50: North America Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Diagnosing Technique, 2021-2026 ($)
Table 51: North America Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Technology, 2021-2026 ($)
Table 52: North America Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Screening Options, 2021-2026 ($)
Table 53: North America Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Instruments, 2021-2026 ($)
Table 54: South america Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Types, 2021-2026 ($)
Table 55: South america Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Diagnosing Technique, 2021-2026 ($)
Table 56: South america Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Technology, 2021-2026 ($)
Table 57: South america Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Screening Options, 2021-2026 ($)
Table 58: South america Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Instruments, 2021-2026 ($)
Table 59: Europe Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Types, 2021-2026 ($)
Table 60: Europe Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Diagnosing Technique, 2021-2026 ($)
Table 61: Europe Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Technology, 2021-2026 ($)
Table 62: Europe Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Screening Options, 2021-2026 ($)
Table 63: Europe Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Instruments, 2021-2026 ($)
Table 64: APAC Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Types, 2021-2026 ($)
Table 65: APAC Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Diagnosing Technique, 2021-2026 ($)
Table 66: APAC Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Technology, 2021-2026 ($)
Table 67: APAC Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Screening Options, 2021-2026 ($)
Table 68: APAC Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Instruments, 2021-2026 ($)
Table 69: Middle East & Africa Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Types, 2021-2026 ($)
Table 70: Middle East & Africa Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Diagnosing Technique, 2021-2026 ($)
Table 71: Middle East & Africa Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Technology, 2021-2026 ($)
Table 72: Middle East & Africa Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Screening Options, 2021-2026 ($)
Table 73: Middle East & Africa Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Instruments, 2021-2026 ($)
Table 74: Russia Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Types, 2021-2026 ($)
Table 75: Russia Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Diagnosing Technique, 2021-2026 ($)
Table 76: Russia Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Technology, 2021-2026 ($)
Table 77: Russia Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Screening Options, 2021-2026 ($)
Table 78: Russia Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Instruments, 2021-2026 ($)
Table 79: Israel Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Types, 2021-2026 ($)
Table 80: Israel Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Diagnosing Technique, 2021-2026 ($)
Table 81: Israel Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Technology, 2021-2026 ($)
Table 82: Israel Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Screening Options, 2021-2026 ($)
Table 83: Israel Prenatal Testing & Newborn Screening Market, Revenue & Volume, By Instruments, 2021-2026 ($)
Table 84: Top Companies 2018 (US$) Prenatal Testing & Newborn Screening Market, Revenue & Volume
Table 85: Product Launch 2018-2019 Prenatal Testing & Newborn Screening Market, Revenue & Volume
Table 86: Mergers & Acquistions 2018-2019 Prenatal Testing & Newborn Screening Market, Revenue & Volume

List of Figures:

Figure 1: Overview of Prenatal Testing & Newborn Screening Market 2021-2026
Figure 2: Market Share Analysis for Prenatal Testing & Newborn Screening Market 2018 (US$)
Figure 3: Product Comparison in Prenatal Testing & Newborn Screening Market 2018-2019 (US$)
Figure 4: End User Profile for Prenatal Testing & Newborn Screening Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Prenatal Testing & Newborn Screening Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Prenatal Testing & Newborn Screening Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Prenatal Testing & Newborn Screening Market 2018-2019
Figure 8: Ecosystem Analysis in Prenatal Testing & Newborn Screening Market 2018
Figure 9: Average Selling Price in Prenatal Testing & Newborn Screening Market 2021-2026
Figure 10: Top Opportunites in Prenatal Testing & Newborn Screening Market 2018-2019
Figure 11: Market Life Cycle Analysis in Prenatal Testing & Newborn Screening Market
Figure 12: GlobalBy Types Prenatal Testing & Newborn Screening Market Revenue, 2021-2026 ($)
Figure 13: GlobalBy Diagnosing Technique Prenatal Testing & Newborn Screening Market Revenue, 2021-2026 ($)
Figure 14: GlobalBy Technology Prenatal Testing & Newborn Screening Market Revenue, 2021-2026 ($)
Figure 15: GlobalBy Screening Options Prenatal Testing & Newborn Screening Market Revenue, 2021-2026 ($)
Figure 16: GlobalBy Instruments Prenatal Testing & Newborn Screening Market Revenue, 2021-2026 ($)
Figure 17: Global Prenatal Testing & Newborn Screening Market - By Geography
Figure 18: Global Prenatal Testing & Newborn Screening Market Value & Volume, By Geography, 2021-2026 ($) 
Figure 19: Global Prenatal Testing & Newborn Screening Market CAGR, By Geography, 2021-2026 (%)
Figure 20: North America Prenatal Testing & Newborn Screening Market Value & Volume, 2021-2026 ($)
Figure 21: US Prenatal Testing & Newborn Screening Market Value & Volume, 2021-2026 ($)
Figure 22: US GDP and Population, 2018-2019 ($)
Figure 23: US GDP – Composition of 2018, By Sector of Origin
Figure 24: US Export and Import Value & Volume, 2018-2019 ($)
Figure 25: Canada Prenatal Testing & Newborn Screening Market Value & Volume, 2021-2026 ($)
Figure 26: Canada GDP and Population, 2018-2019 ($)
Figure 27: Canada GDP – Composition of 2018, By Sector of Origin
Figure 28: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 29: Mexico Prenatal Testing & Newborn Screening Market Value & Volume, 2021-2026 ($)
Figure 30: Mexico GDP and Population, 2018-2019 ($)
Figure 31: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 32: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 33: South America Prenatal Testing & Newborn Screening Market Value & Volume, 2021-2026 ($)
Figure 34: Brazil Prenatal Testing & Newborn Screening Market Value & Volume, 2021-2026 ($)
Figure 35: Brazil GDP and Population, 2018-2019 ($)
Figure 36: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 37: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 38: Venezuela Prenatal Testing & Newborn Screening Market Value & Volume, 2021-2026 ($)
Figure 39: Venezuela GDP and Population, 2018-2019 ($)
Figure 40: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 41: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 42: Argentina Prenatal Testing & Newborn Screening Market Value & Volume, 2021-2026 ($)
Figure 43: Argentina GDP and Population, 2018-2019 ($)
Figure 44: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 45: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 46: Ecuador Prenatal Testing & Newborn Screening Market Value & Volume, 2021-2026 ($)
Figure 47: Ecuador GDP and Population, 2018-2019 ($)
Figure 48: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 49: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 50: Peru Prenatal Testing & Newborn Screening Market Value & Volume, 2021-2026 ($)
Figure 51: Peru GDP and Population, 2018-2019 ($)
Figure 52: Peru GDP – Composition of 2018, By Sector of Origin
Figure 53: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 54: Colombia Prenatal Testing & Newborn Screening Market Value & Volume, 2021-2026 ($)
Figure 55: Colombia GDP and Population, 2018-2019 ($)
Figure 56: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 57: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 58: Costa Rica Prenatal Testing & Newborn Screening Market Value & Volume, 2021-2026 ($)
Figure 59: Costa Rica GDP and Population, 2018-2019 ($)
Figure 60: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 61: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 62: Europe Prenatal Testing & Newborn Screening Market Value & Volume, 2021-2026 ($)
Figure 63: U.K Prenatal Testing & Newborn Screening Market Value & Volume, 2021-2026 ($)
Figure 64: U.K GDP and Population, 2018-2019 ($)
Figure 65: U.K GDP – Composition of 2018, By Sector of Origin
Figure 66: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 67: Germany Prenatal Testing & Newborn Screening Market Value & Volume, 2021-2026 ($)
Figure 68: Germany GDP and Population, 2018-2019 ($)
Figure 69: Germany GDP – Composition of 2018, By Sector of Origin
Figure 70: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 71: Italy Prenatal Testing & Newborn Screening Market Value & Volume, 2021-2026 ($)
Figure 72: Italy GDP and Population, 2018-2019 ($)
Figure 73: Italy GDP – Composition of 2018, By Sector of Origin
Figure 74: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 75: France Prenatal Testing & Newborn Screening Market Value & Volume, 2021-2026 ($)
Figure 76: France GDP and Population, 2018-2019 ($)
Figure 77: France GDP – Composition of 2018, By Sector of Origin
Figure 78: France Export and Import Value & Volume, 2018-2019 ($)
Figure 79: Netherlands Prenatal Testing & Newborn Screening Market Value & Volume, 2021-2026 ($)
Figure 80: Netherlands GDP and Population, 2018-2019 ($)
Figure 81: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 82: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 83: Belgium Prenatal Testing & Newborn Screening Market Value & Volume, 2021-2026 ($)
Figure 84: Belgium GDP and Population, 2018-2019 ($)
Figure 85: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 86: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 87: Spain Prenatal Testing & Newborn Screening Market Value & Volume, 2021-2026 ($)
Figure 88: Spain GDP and Population, 2018-2019 ($)
Figure 89: Spain GDP – Composition of 2018, By Sector of Origin
Figure 90: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 91: Denmark Prenatal Testing & Newborn Screening Market Value & Volume, 2021-2026 ($)
Figure 92: Denmark GDP and Population, 2018-2019 ($)
Figure 93: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 94: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 95: APAC Prenatal Testing & Newborn Screening Market Value & Volume, 2021-2026 ($)
Figure 96: China Prenatal Testing & Newborn Screening Market Value & Volume, 2021-2026
Figure 97: China GDP and Population, 2018-2019 ($)
Figure 98: China GDP – Composition of 2018, By Sector of Origin
Figure 99: China Export and Import Value & Volume, 2018-2019 ($) Prenatal Testing & Newborn Screening Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 100: Australia Prenatal Testing & Newborn Screening Market Value & Volume, 2021-2026 ($)
Figure 101: Australia GDP and Population, 2018-2019 ($)
Figure 102: Australia GDP – Composition of 2018, By Sector of Origin
Figure 103: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 104: South Korea Prenatal Testing & Newborn Screening Market Value & Volume, 2021-2026 ($)
Figure 105: South Korea GDP and Population, 2018-2019 ($)
Figure 106: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 107: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 108: India Prenatal Testing & Newborn Screening Market Value & Volume, 2021-2026 ($)
Figure 109: India GDP and Population, 2018-2019 ($)
Figure 110: India GDP – Composition of 2018, By Sector of Origin
Figure 111: India Export and Import Value & Volume, 2018-2019 ($)
Figure 112: Taiwan Prenatal Testing & Newborn Screening Market Value & Volume, 2021-2026 ($)
Figure 113: Taiwan GDP and Population, 2018-2019 ($)
Figure 114: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 115: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 116: Malaysia Prenatal Testing & Newborn Screening Market Value & Volume, 2021-2026 ($)
Figure 117: Malaysia GDP and Population, 2018-2019 ($)
Figure 118: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 119: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 120: Hong Kong Prenatal Testing & Newborn Screening Market Value & Volume, 2021-2026 ($)
Figure 121: Hong Kong GDP and Population, 2018-2019 ($)
Figure 122: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 123: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 124: Middle East & Africa Prenatal Testing & Newborn Screening Market Middle East & Africa 3D Printing Market Value & Volume, 2021-2026 ($)
Figure 125: Russia Prenatal Testing & Newborn Screening Market Value & Volume, 2021-2026 ($)
Figure 126: Russia GDP and Population, 2018-2019 ($)
Figure 127: Russia GDP – Composition of 2018, By Sector of Origin
Figure 128: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 129: Israel Prenatal Testing & Newborn Screening Market Value & Volume, 2021-2026 ($)
Figure 130: Israel GDP and Population, 2018-2019 ($)
Figure 131: Israel GDP – Composition of 2018, By Sector of Origin
Figure 132: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 133: Entropy Share, By Strategies, 2018-2019* (%) Prenatal Testing & Newborn Screening Market 
Figure 134: Developments, 2018-2019* Prenatal Testing & Newborn Screening Market 
Figure 135: Company 1 Prenatal Testing & Newborn Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 136: Company 1 Prenatal Testing & Newborn Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 137: Company 1 Prenatal Testing & Newborn Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 138: Company 2 Prenatal Testing & Newborn Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 139: Company 2 Prenatal Testing & Newborn Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 140: Company 2 Prenatal Testing & Newborn Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 141: Company 3 Prenatal Testing & Newborn Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 142: Company 3 Prenatal Testing & Newborn Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 143: Company 3 Prenatal Testing & Newborn Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 144: Company 4 Prenatal Testing & Newborn Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 145: Company 4 Prenatal Testing & Newborn Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 146: Company 4 Prenatal Testing & Newborn Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 147: Company 5 Prenatal Testing & Newborn Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 148: Company 5 Prenatal Testing & Newborn Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 149: Company 5 Prenatal Testing & Newborn Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 150: Company 6 Prenatal Testing & Newborn Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 151: Company 6 Prenatal Testing & Newborn Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 152: Company 6 Prenatal Testing & Newborn Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 153: Company 7 Prenatal Testing & Newborn Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 154: Company 7 Prenatal Testing & Newborn Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 155: Company 7 Prenatal Testing & Newborn Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 156: Company 8 Prenatal Testing & Newborn Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 157: Company 8 Prenatal Testing & Newborn Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 158: Company 8 Prenatal Testing & Newborn Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 159: Company 9 Prenatal Testing & Newborn Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 160: Company 9 Prenatal Testing & Newborn Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 161: Company 9 Prenatal Testing & Newborn Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 162: Company 10 Prenatal Testing & Newborn Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 163: Company 10 Prenatal Testing & Newborn Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 164: Company 10 Prenatal Testing & Newborn Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 165: Company 11 Prenatal Testing & Newborn Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 166: Company 11 Prenatal Testing & Newborn Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 167: Company 11 Prenatal Testing & Newborn Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 168: Company 12 Prenatal Testing & Newborn Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 169: Company 12 Prenatal Testing & Newborn Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 170: Company 12 Prenatal Testing & Newborn Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 171: Company 13 Prenatal Testing & Newborn Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 172: Company 13 Prenatal Testing & Newborn Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 173: Company 13 Prenatal Testing & Newborn Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 174: Company 14 Prenatal Testing & Newborn Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 175: Company 14 Prenatal Testing & Newborn Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 176: Company 14 Prenatal Testing & Newborn Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 177: Company 15 Prenatal Testing & Newborn Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 178: Company 15 Prenatal Testing & Newborn Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 179: Company 15 Prenatal Testing & Newborn Screening Market Net Sales Share, By Geography, 2018 (%)